This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Campus
  1. Resource
  2. Source: Campus Sanofi
  3. 1 Nov 2024

Praluent® (alirocumab) Patient Resources

Author: Sanofi

Editorial Team

Praluent logo

Prescribing Information(GB)

Prescribing Information(NI)

Disclaimer: The resources contained within this section are updated regularly by Sanofi. Before you use any of the resources, or provide any resources to your patients please re-visit this page to ensure that you are using the most up-to-date version(s).

Order patient materials either via your local representative or Contact Medical Information on +44 (0) 800 035 2525 (Monday – Friday, 8:30-17:30, excluding public holidays)

Training materials

RESOURCES FOR PRALUENT® 75MG OR 150MG

▶ How to Inject Praluent® (video)

▶ Digital Starter Pack (PDF)

▶ Praluent® Injection Guide (PDF)

▶ Living with High Cholesterol (PDF)

1/3

▶ Digital Starter Pack (PDF)

▶ Praluent® Injection Guide (PDF)

▶ Living with High Cholesterol (PDF)

RESOURCES FOR PRALUENT® 300MG

▶ How to Inject Praluent® (video)

▶ Digital Starter Pack (PDF)

▶ Praluent® Injection Guide (PDF)

▶ Living with High Cholesterol (PDF)

1/3

▶ Digital Starter Pack (PDF)

▶ Praluent® Injection Guide (PDF)

▶ Living with High Cholesterol (PDF)

Links of interest

Website: MyPraluent® - This website was developed and funded by Sanofi

Patient Information Leaflet 75mg (sourced from Medicines.org.uk)

Patient Information Leaflet 150mg (sourced from Medicines.org.uk)

Patient Information Leaflet 150mg (sourced from Medicines.org.uk)

Patient Information leaflet 300mg (sourced from Medicines.org.uk)

1/5

Website: MyPraluent® - This website was developed and funded by Sanofi

Patient Information Leaflet 75mg (sourced from Medicines.org.uk)

Patient Information Leaflet 150mg (sourced from Medicines.org.uk)

Patient Information Leaflet 150mg (sourced from Medicines.org.uk)

Patient Information leaflet 300mg (sourced from Medicines.org.uk)

1/2

Disclaimer: The above resources should be downloaded and given to your patient(s) who have been prescribed Praluent®, or can be shown to your patient(s) during consultation. Your patient(s) must not be directed towards this website as it is intended for healthcare professionals only.

SEE MORE FROM SCIENCE

Praluent®

Find more information on Indication, Administration and Mechanism of Action and watch videos about Praluent®.

Patient Website

Find resources and support for your patients on Praluent®. Find useful links about how patients can manage their cholesterol.

Get in touch with the Dyslipidaemia Team
MAT-XU-2201545 (v5.0) Date of Preparation: October 2023

MAT-XU-2204602 (v8.0) Date of Preparation: November 2024